Chuck Triano
Senior Vice President and Head of Investor Relations
Replay available
Bristol-Myers Squibb Company (BMY) Q1 2026 Earnings Call
Bristol-Myers Squibb Company (NYSE: BMY) Q1 2026 earnings conference call, held 2026-04-30. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Chris Berner
Board Chair and Chief Executive Officer
David Elkins
Chief Financial Officer
Christian Massachese
Chief Medical Officer and Head of Global Drug Development
Adam Lemkowski
Chief Commercialization Officer
Asad Haider
Analyst, Goldman Sachs
Jeff Meacham
Analyst, Citi
Alexandra Hammond
Analyst, Wolf Research
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Bristol-myers Squibb Company.
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:06.099 Welcome to the Bristol-Myers Squibb first quarter 2026 earnings conference call. 00:00:06.099 -- 00:00:09.323 All participants will be in a listen only mode. 00:00:09.323 -- 00:00:13.128 Should you need assistance, please signal a conference specialist by pressing the star 00:00:13.128 -- 00:00:15.491 key followed by zero. 00:00:15.491 -- 00:00:20.498 After today's presentation, there will be an opportunity to ask questions. 00:00:20.498 -- 00:00:25.504 To ask a question, you may press star then one on your telephone keypad. 00:00:25.504 -- 00:00:29.731 To withdraw your question, please press star then two. 00:00:29.731 -- 00:00:32.823 Please note this event is being recorded. 00:00:32.823 -- 00:00:37.561 I would now like to turn the conference over to Chuck Triano, Senior Vice President and 00:00:37.561 -- 00:00:42.131 Head of Investor Relations. Please go ahead. 00:00:43.096 -- 00:00:47.080 Thank you and good morning, everyone. We appreciate you joining our first quarter 2026 00:00:47.080 -- 00:00:51.585 earnings call. With me this morning with prepared remarks are Chris Berner, our board 00:00:51.585 -- 00:00:55.590 chair and chief executive officer, and David Elkins, our chief financial officer. 00:00:55.590 -- 00:01:00.435 Also participating in today's call is Adam Lemkowski, our chief commercialization officer, 00:01:00.435 -- 00:01:05.341 and Christian Massachese, our chief medical officer and head of global drug development. 00:01:05.341 -- 00:01:09.946 Earlier this morning, we posted our quarterly slide presentation to bms.com that you 00:01:09.946 -- 00:01:13.201 can use to follow along with Chris and David's remarks. 00:01:13.201 -- 00:01:17.050 Before we get started, I'll remind everybody that during this call, we will ...